Equities
Health CarePharmaceuticals and Biotechnology
  • Price (HKD)24.55
  • Today's Change-1.45 / -5.58%
  • Shares traded5.01m
  • 1 Year change-12.01%
  • Beta--
Data delayed at least 15 minutes, as of Nov 22 2024 08:08 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
REVENUE AND GROSS PROFIT
Total revenue2,124990311
OPERATING EXPENSES
Cost of revenue total1,564729198
Selling, general and admin. expenses, total1179335
Depreciation/amortization--106.45
Unusual expense(income)5400
Other operating expenses, total(45)(22)(9.07)
Total operating expense1,763792244
Operating income36019967
Other, net------
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes36019667
Provision for income taxes764012
Net income after taxes28415655
Minority interest------
Net income before extra. Items28415655
Total extraordinary items------
Net income28415655
Inc.avail. to common excl. extra. Items28415655
Inc.avail. to common incl. extra. Items28415655
EPS RECONCILIATION
Basic/primary weighted average shares1,0231,1781,178
Basic/primary eps excl. extra items0.280.130.05
Basic/primary eps incl. extra items0.280.130.05
Dilution adjustment------
Diluted weighted average shares1,0781,1781,178
Diluted eps excl. extra items0.260.130.05
Diluted eps incl. extra items0.260.130.05
COMMON STOCK DIVIDENDS
DPS - common stock primary issue------
Gross dividend - common stock000
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental0.742.920.49
SUPPLEMENTAL INCOME
Depreciation, supplemental512217
Total special items54(0.07)(0.11)
NORMALISED INCOME
Normalized income before taxes41419667
Effect of special items on income taxes11(0.01)(0.02)
Income tax excluding impact of special items874012
Normalized income after tax32615655
Normalized income avail. to common32615655
Basic normalized EPS0.320.130.05
Diluted normalized EPS0.300.130.05
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.